Inventor · disambiguated record
Magdolna Torok
Also filed as: TOEROEK MAGDOLNA · TOEROEK MAGDOLNA BATHONE · TOROK MAGDOLNA · TOROK MAGDOLNA BATHONE
8 granted patents·2 pending applications·106 citations·filing 1997–2009
88Inventor score
Files withCYTRX CORP5BIOREX KUTATO FEJLESZTOE KFT2BIOREX KUTATO ES FEJLESZOERT1BIOREX KUTATO FEJLESZTOE RT1
Top patents by PatentIndex Score
10 records- 0193US7691849B2Carboxamidine derivatives and their use in the treatment of vascular diseasesCYTRX CORP·Filed 2007·Granted Apr 6, 2010·14 cites·27 claims
- 0290US7550457B2Pharmaceutically effective compoundsCYTRX CORP·Filed 2007·Granted Jun 23, 2009·13 cites·19 claims
- 0384US6649628B1N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistanceBIOREX KUTATO FEJLESZTOE KFT·Filed 2000·Granted Nov 18, 2003·32 cites·10 claims
- 0483US7384936B2Carboxamidine derivatives and their use in the treatment of vascular diseasesCYTRX CORP·Filed 2003·Granted Jun 10, 2008·14 cites·10 claims
- 0582US7361655B2Pharmaceutically effective compoundsCYTRX CORP·Filed 2004·Granted Apr 22, 2008·13 cites·11 claims
- 0676US2009253690A1Pharmaceutically effective compoundsCYTRX CORP·Filed 2009·Application pending·0 cites
- 0748US6384029B1Optically active pyridyl-4h-1,2,4-oxdadiazine derivative and its use in the treatment of vascular diseasesBIOREX KUTATO FEJLESZTOE RT·Filed 1999·Granted May 7, 2002·13 cites·13 claims
- 0836US6143741APharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cellsBIOREX KUTATO ES FEJLESZOERT·Filed 1997·Granted Nov 7, 2000·7 cites·15 claims
- 0936US2001051630A1Use of hydroxylamine derivatives, and method and preparations for increasing the tolerance of field crops against weather stressesFiled 2001·Application pending·0 cites
- 1029US6180787B1Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halidesBIOREX KUTATO FEJLESZTOE KFT·Filed 1997·Granted Jan 30, 2001·0 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →